Blockade of PD-1 in Conjunction With the Dendritic Cell/AML Vaccine Following Chemotherapy Induced Remission

NCT01096602 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
63
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Beth Israel Deaconess Medical Center

Collaborators